DOP53: Community types of the human gut virome are associated with endoscopic outcome in UC patientsECCO’23 CopenhagenYear: 2023
Authors: Jansen, D.(1)*;Falony, G.(2);Vieira-Silva, S.(3);Simsek, C.(1);Marcelis, T.(1);Machiels, K.(4);Caenepeel, C.(4);Raes, J.(2);Severine, V.(4);Matthijnssens, J.(1);
(1)Lab of Viral Metagenomics, Department of Microbiology- Immunology and Transplantation, Leuven, Belgium;(2)Laboratory of Molecular Bacteriology, Department of Microbiology- Immunology and Transplantation, Leuven, Belgium;(3)Institute of Medical Microbiology and Hygiene, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany;(4)Translational Research Center for Gastrointestinal Disorders TARGID, University Hospitals Leuven, Leuven, Belgium;
DOP54: Time to effect of biologics and small molecules for patients with moderately to severely active luminal Crohn's disease – a systematic review and network meta-analysisECCO’23 CopenhagenYear: 2023
Authors: Attauabi, M.(1,2)*;Steenholdt, C.(1);Burisch, J.(2,3);Gubatan, J.(4);Nielsen, O.H.(1);Seidelin, J.B.(1);
(1)Copenhagen University Hospital - Herlev and Gentofte, Department of Gastroenterology and Hepatology, Herlev, Denmark;(2)Hvidovre Hospital, Copenhagen Center for Inflammatory Bowel Disease in Children- Adolescents- and Adults, Hvidovre, Denmark;(3)Copenhagen University Hospital - Amager and Hvidovre, Gastrounit- Medical Section, Hvidovre, Denmark;(4)Stanford University School of Medicine, Division of Gastroenterology and Hepatology, Stanford, Denmark;
DOP56: Long-term disease progression and resective surgery rates in Crohn's disease over different therapeutic eras – a population-based study from western Hungary between 1977–2020, data from the Veszprem county cohortECCO’23 CopenhagenYear: 2023
Authors: Gonczi, L.(1);Lakatos, L.(2)*;Golovics, P.A.(3);Pandur, T.(4);David, G.(2);Erdélyi, Z.(2);Szita, I.(2);LakatosPhD, P.L.(5);
(1)Semmelweis University, Department of Medicine and Oncology, Budapest, Hungary;(2)Ferenc Csolnoky Hospital, Department of Gastroenterology, Veszprem, Hungary;(3)Hungarian Defence Forces Medical Centre, Department of Gastroenterology, Budapest, Hungary;(4)Grof Esterhazy Hospital, Department of Gastroenterology, Papa, Hungary;(5)Mcgill University Health Center, IBD Centre, Montréal, Canada;
DOP57: GLP-1 based therapies and risk of Inflammatory Bowel Disease: real world evidence from a nationwide cohort studyECCO’23 CopenhagenYear: 2023
Authors: Christensen, H.S.(1)*;Andersen, D.(2);Jess, T.(2);Allin, K.H.(2);
(1)Aalborg University, PREDICT- Department of Clinical Medicine, Aalborg, Denmark;(2)Aalborg University, PREDICT- Department of Clinical Medicine, Copenhagen, Denmark;
DOP58: predictors of complicated disease course in CD in an administrative database: a nationwide study from the epi-IIRNECCO’23 CopenhagenYear: 2023
Authors: Lujan, R.(1);Atia, O.(1);Gili, F.(1)*;Greenfeld, S.(2);Kariv, R.(2);Loewenberg Weisband, Y.(3);Lederman, N.(4);Matz, E.(5);Dotan, I.(6);Turner, D.(1);
(1)Shaare Zedek Medical Center, Juliet Keidan Institute of Pediatric Gastroenterology Hepatology and Nutrition, Jerusalem, Israel;(2)Israel and the Sackler Faculty of Medicine, Maccabi Health Services, Tel Aviv, Israel;(3)Clalit Research Institute, Clalit Health Services, Tel Aviv, Israel;(4)Medical Division, Meuhedet Sick Fund, Tel Aviv, Israel;(5)Leumit Health Services, Leumit Health Services, Tel Aviv, Israel;(6)Rabin Medical Center and the Sackler Faculty of Medicine, Division of Gastroenterology, Petah Tikva, Israel;
DOP59: What is the relationship between fatigue, pain and urgency in people with inflammatory bowel disease? Results of the IBD-BOOST survey in 8486 participantsECCO’23 CopenhagenYear: 2023
Authors: Hart, A.(1);Miller, L.(2);Hamborg, T.(2);Stagg, I.(1);McGuinness, S.(3);Wileman, V.(4);Tzorovili, E.(2);Mihaylova, B.(2);Roukas, C.(2);Aziz, Q.(5);Czuber-Dochan, W.(3);Dibley, L.(6);Moss-Morris, R.(7);Pollok, R.(8);Saxena, S.(9);Winsor, G.(10);Norton, C.(3)*;
(1)St Mark's Hospital, Inflammatory Bowel Disease Unit, London, United Kingdom;(2)Queen Mary University of London, Pragmatic Clinical Trials Unit, London, United Kingdom;(3)King's College- London, Florence Nightingale Faculty of Nursing- Midwifery and Palliative Care, London, United Kingdom;(4)King's College London, Health Psychology-Institute of Psychiatry- Psychology and Neuroscience, London, United Kingdom;(5)Queen Mary University of London, Centre of Neuroscience- Surgery and Trauma- Blizard Institute- Wingate Institute of Neurogastroenterology, London, United Kingdom;(6)University of Greenwich, Institute for Lifecourse Development- Centre for Chronic Illness and Ageing, London, United Kingdom;(7)King's College London, Health Psychology- Institute of Psychiatry- Psychology and Neuroscience, London, United Kingdom;(8)St George's Hospital, Gastroenterology, London, United Kingdom;(9)Imperial College London, Department of Primary Care and Public Health, London, United Kingdom;(10)Crohn's & Colitis UK, Research, Hatfield, United Kingdom;
DOP60: Environmental risk factors for Inflammatory bowel disease: A large prospective case-control study in IndiaECCO’23 CopenhagenYear: 2023
Authors: Banerjee, R.(1)*;Pal, P.(1);Prakash, N.(1);Mudigonda, S.(1);Joseph, S.(1);Patel, R.(1);Khalil, M.(1);Komawar, A.(1);Korikana, S.(1);Mekala, D.(1);Akki, Y.(1);Gaddam, A.(1);Valluri, S.(1);
(1)Asian Institute of Gastroenterology, IBD Centre, Hyderabad, India;
DOP61: Ethnic disparities in the management of Inflammatory Bowel Disease in Israel and impact on outcomesECCO’23 CopenhagenYear: 2023
Authors: Boaz, E.(1)*;Ledder, O.(2);Dagan, A.(1);Lujan, R.(2);Koslowsky, B.(3);Friss, C.(2);Greenfeld, S.(4);Kariv, R.(4);Loewenberg Weisband , Y.(5);Lederman, N.(6);Matz, E.(7);Dotan, I.(8);Yellinek, S.(1);Turner, D.(2);
(1)Shaare Zedek Medical Center, General Surgery, Jerusalem, Israel;(2)Shaare Zedek Medical Center, Institute of Pediatric Gastroenterology and Nutrition, Jerusalem, Israel;(3)Shaare Zedek Medical Center, Digestive Disease Institue, Jerusalem, Israel;(4)Maccabi Health Services, Maccabi Health Services, Tel Aviv, Israel;(5)Clalit Health Services, Clalit Research Institute, Tel Aviv, Israel;(6)Meuhedet Health Services, Meuhedet Health Services, Tel Aviv, Israel;(7)Leumit Health Services, Leumit Health Services, Tel Aviv, Israel;(8)Rabin Medical Center, Division of Gastroenterology, Petah Tikva, Israel;
DOP62: Medication use is increased in the decade prior to IBD diagnosis: A nationwide cohort studyECCO’23 CopenhagenYear: 2023
Authors: Bonfils, L.(1)*;Karachalia Sandri, A.(1);Juul Poulsen, G.(1);Agrawal, M.(1,2);Ward, D.J.(1);Jess, T.(1,3);Colombel, J.F.(2);H. Allin, K.(1,3);
(1)Center for Molecular Prediction of Inflammatory Bowel Disease PREDICT- Aalborg University- Copenhagen- Denmark, Department of Clinical Medicine, Copenhagen, Denmark;(2)The Dr. Henry D. Janowitz Division of Gastroenterology- Icahn School of Medicine at Mount Sinai- New York NY, The Dr. Henry D. Janowitz Division of Gastroenterology, New York City, United States;(3)Department of Gastroenterology & Hepatology- Aalborg University Hospital- Aalborg- Denmark, Department of Gastroenterology & Hepatology, Aalborg, Denmark;
DOP63: Time Trends of Environmental and Socio-economical Factors in Patients with Inflammatory Bowel Disease over 40-year of Different Therapeutic Eras; results from a Population-based Cohort from Western Hungarian between 1977-2020, The Hygiene hypothesis revisited.ECCO’23 CopenhagenYear: 2023
Authors: Wetwittayakhlang, P.(1);Gonczi , L.(2);Lakatos , L.(3);Golovics , P.(4);Pandur , T.(5);David , G.(3);Erdelyi , Z.(3);Szita , I.(3);LakatosPhD, P.L.(6)*;
(1)McGill University Health Centre, IBD center- Division of Gastroenterology and Hepatology, Montreal, Canada;(2)Semmelweis University, Department of Internal Medicine and Oncology, Budapest, Hungary;(3)Ferenc Csolnoky Hospital, Department of Gastroenterology, Veszprem, Hungary;(4)Hungarian Defence Forces Medical Centre, Department of Gastroenterology, Budapest, Hungary;(5)Grof Eszterhazy Hospital, Department of Gastroenterology, Papa, Hungary;(6)McGill University Health Center, IBD center- Division of Gastroenterology and Hepatology, Montreal, Canada;
DOP64: Utilising genomics to predict outcomes and delineate novel subgroups in inflammatory bowel diseaseECCO’23 CopenhagenYear: 2023
Authors: Ashton, J.(1,2)*;Cheng, G.(2);Stafford, I.(2);Beattie, R.M.(1);Ennis, S.(2);
(1)Southampton Children's Hospital, Department of Paediatric Gastroenterology, Southampton, United Kingdom;(2)University of Southampton, Human Genetics and Genomic Medicine, Southampton, United Kingdom;
DOP65: T-cell derived TGFβ1 remodels the rectum mesenchyme in Crohn's Disease patients with perianal fistulizing diseaseECCO’23 CopenhagenYear: 2023
Authors: Gudiño, V.(1)*;Cho, J.W.(2);Corraliza, A.M.(1);Caballol, B.(3);Garrido-Trigo, A.(1);Masamunt, M.C.(3);Ordás, I.(3);Ricart, E.(3);Hemberg, M.(2);Panés, J.(3);Salas, A.(1);
(1)Institut d'Investigacions Biomèdiques August Pi i Sunyer IDIBAPS, Inflammatory Bowel Disease Unit, Barcelona, Spain;(2)Evergrande Centre- Brigham and Women's Hospital, Quantitative models of gene expression, Boston, United States;(3)Hospital Clinic, Inflammatory Bowel Disease Unit, Barcelona, Spain;
DOP66: Ileal resections from fibrotic-CD patients present microbiota dysbiosis, altered metabolomic profiles and metabolite-sensing GPCRs expressionECCO’23 CopenhagenYear: 2023
Authors: Bauset, C.(1)*;Carda-Diéguez, M.(2);Buetas, E.(2);Lis-López, L.(1);Seco-Cervera, M.(3);Coll, S.(1);Ortiz-Masiá, D.(4);Calatayud, S.(5);Barrachina, M.D.(5);Mira, Á.(6);Cosín-Roger, J.(3);
(1)Universitat de València, Pharmacology, València, Spain;(2)FISABIO, Genomics and Health, València, Spain;(3)Universitat de València-FISABIO, Pharmacology, València, Spain;(4)Universitat de València-CIBERehd, Medicine, València, Spain;(5)Universitat de València-CIBERehd, Pharmacology, València, Spain;(6)FISABIO-CIBERESP, Genomics and Health, València, Spain;
DOP68: Autophagy induction in the intestinal epithelium protects against inflammation-induced barrier loss in vivo.ECCO’23 CopenhagenYear: 2023
Authors: Saha, K.(1)*;Ganapathy, A.S.(1);Wang, A.(1);Morris, N.(1);Yochum, G.(2);Koltun, W.(2);Ding, W.(2);Nighot, M.(1);Ma, T.(1);Nighot, P.(1);
(1)Penn State College of Medicine, Medicine, Hershey, United States;(2)Penn State College of Medicine, Surgery, Hershey, United States;
DOP69: Glycans as an actor in the microbiome-immune response crosstalk.ECCO’23 CopenhagenYear: 2023
Authors: Rodrigues, C.(1);Gaifem, J.(2);Pereira, M.(2);Lavelle, A.(3);Colombel, J.F.(4);Sokol, H.(5);Pinho, S.(6)*;
(1)ICBAS- School of Medicine and Biomedical Sciences and i3S - University of Porto, Immunology- Cancer & GlycoMedicine, Porto, Portugal;(2)i3S - University of Porto, Immunology- Cancer & GlycoMedicine, Porto, Portugal;(3)Sorbonne University, Na, Paris, France;(4)Icahn School of Medicine Mount Sinai, Na, New York, United States;(5)Saint-Antoine Hospital, Na, Paris, France;(6)i3S-University of Porto, Immunology- Cancer andGlycoMedicine group, Porto, Portugal;
DOP70: Crohn's Disease Like Inflammation of The Pouch is a Distinct Type of PouchitisECCO’23 CopenhagenYear: 2023
Authors: Kayal, M.(1)*;Tankelevich, M.(2);Guo, Y.(3);Fischer, J.(4);Jimenez, D.(5);Canales-Herrerias, P.(2);Livanos, A.(2);Colombel, J.F.(1);Dubinsky, M.(6);Faith, J.(4);Ko, H.(3);Mehandru, S.(2);
(1)Icahn School of Medicine at Mount Sinai, Medicine/Gastroenterology, New York, United States;(2)Icahn School of Medicine at Mount Sinai, Gastroenterology/Immunology, New York, United States;(3)Columbia University Medical Center, Pathology, New York, United States;(4)Icahn School of Medicine at Mount Sinai, Genetics and Genomic Sciences, New York, United States;(5)Icahn School of Medicine at Mount Sinai, Gastroenterology, New York, United States;(6)Icahn School of Medicine at Mount Sinai, Pediatrics/Gastroenterology, New York, United States;
DOP71: TREM1, OSM and a co-expressed transcriptional module are core components of the molecular resistome to anti-cytokine therapy in Ulcerative ColitisECCO’23 CopenhagenYear: 2023
Authors: Saifuddin, A.(1)*;Madgwick, M.(2);Cozzetto, D.(1);Pavlidis, P.(3);Verstockt, B.(4,5);Hart, A.(1,6);Korcsmaros, T.(1);Powell, N.(1);
(1)Imperial College London, Department of Metabolism- Digestion and Reproduction, London, United Kingdom;(2)Earlham Institute, Organisms and Ecosystems, Norwich, United Kingdom;(3)King's College Hospital NHS Trust, Department of Gastroenterology, London, United Kingdom;(4)University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;(5)KU Leuven, Department of Chronic Diseases and Metabolism, Leuven, United Kingdom;(6)St Mark's Academic Institute, Department of Gastroenterology, London, United Kingdom;
